Prescription Audit in OPD of NABH & JCI Approved Hospital in Capital Territory of India

A Prescription Audit In The Outpatient Department Of Nabh & Jci Approved Super Speciality Hospital In The Capital Territory Of India

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient.

Need of study:

For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve quality standards and quality of care For implication of professional practices To identify and eliminate deficient practice

Objectives:

1. To study the quality of good prescription
2. In minimization of prescription errors and medication errors
3. Also to comply with good clinical practice
4. Enhancement of patient safety
5. In the maintenance of rational prescribing
6. To study the quality of care provided by the hospital to the patient

Plan of study:

• To select the patient based on inclusion and exclusion criteria
• To collect the information from OP's prescription
• To identify prescribing errors and medication error
• To study the management of good prescription

Study Sites: Max Super Speciality Hospital, Saket, New Delhi (INDIA) Study Design: Observational cohort study Study Duration: 1 month (November 2022)

Study Overview

• Status: Completed
• Conditions: Quality of Life
• Intervention / Treatment: Other: Mentioned

Detailed Description

Source of the data: Review of out-patient prescription Sample size: 100 prescription

Possible outcomes:

Minimization of prescribing errors It improves the quality of care Enhancement of patient safety Compliance with good clinical practice In the maintenance of rational prescribing

• Study Type: Observational
• Enrollment (Actual): 100

Contacts and Locations

Study Locations

• India
  • Delhi
    • New Delhi, Delhi, India, 110017
      • Max Super Speciality Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Any patient prescription which is randomly picked during study period

Description

Inclusion Criteria:

• Participants who are willing to participate.
• Participants who are attending in the out-patient department.
• Participants reported during the study period.
• Participants who have a prescription which is legible and complete.

Exclusion Criteria:

• Participants who are unwilling to provide the required information.
• Participants who are not attending the out-patient department.
• Participants whose prescription is not legible and competent

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Compliance; Prescription is filled for specific parameters	Other: Mentioned; If prescription is properly filled for specific details than it is compliance; Other Names: Prescription is properly filled
Non-compliance; Prescription is not filled for specific parameters	Other: Mentioned; If prescription is properly filled for specific details than it is compliance; Other Names: Prescription is properly filled
Not available - NA; Data not available	Other: Mentioned; If prescription is properly filled for specific details than it is compliance; Other Names: Prescription is properly filled

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percentage of prescription	Data is available sufficient	November 01, 2022 to November 30, 2022

Collaborators and Investigators

• Sponsor: Kakatiya University

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2022
• Primary Completion (Actual): January 1, 2023
• Study Completion (Actual): January 1, 2023

Study Registration Dates

• First Submitted: January 31, 2023
• First Submitted That Met QC Criteria: February 14, 2023
• First Posted (Actual): February 15, 2023

Study Record Updates

• Last Update Posted (Actual): June 7, 2023
• Last Update Submitted That Met QC Criteria: June 6, 2023
• Last Verified: June 1, 2023

More Information

Terms related to this study

• Keywords: Gender difference; Medical Audit; Prescription Audit
• Other Study ID Numbers: MAX/IEC/2022/NOV/PA01

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: If planned, definitely it would be notified

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No